Search results
Showing: 10 of 441
Drug Tariff News - November Part VIIIA reimbursement prices
The Department of Health has agreed that the November Drug Tariff Part VIIIA reimbursement price for the following items will be:
Ethosuximide 250mg capsules £173.00
Mirtazapine 30mg tablets £1.50
and not as printed in the November edition of…
Drug Tariff News - November Part VIIIA reimbursement prices
The Department of Health has agreed that the November Drug Tariff Part VIIIA reimbursement price for the following items will be:
Mirtazapine 15mg tablets £4.65
Mirtazapine 45mg tablets £5.95
and not as printed in the November edition of the…
Drug Tariff News - December Part VIIIA Reimbursement Prices
The Department of Health has agreed that the December Drug Tariff PartV IIIA price for
Zolmitriptan 2.5mg tablets £13.70
and not as printed in the December edition of the Drug Tariff.
Drug Tariff News - January Part VIIIA reimbursement prices
The Department of Health has agreed that the January Drug Tariff Part VIIIA reimbursement price for the following item will be:
Docusate 50mg/5ml oral solution sugar free £7.99
and not as printed in the January edition of the Drug Tariff.
NHS Prescription Services
NHS Prescription Services calculates the remuneration and reimbursement due to dispensing contractors across England.
Visit our NHS prescription charges section for information on prescription prepayment certificates, who gets free prescriptions…
Prescribing budgets
ICBs are responsible for setting a prescribing budget against each GP practice within their organisation.
Annual prescribing budgets
Following the completion of March’s prescribing data, NHS Prescription Services will send an annual prescribing…
dm+d for pharmaceutical suppliers and manufacturers
Suppliers of medicinal products and medical devices have a key role to play in supporting the maintenance of and updating dm+d.
Listing products on dm+d is the only way for pharmaceutical suppliers and manufacturers to make sure their products…
Re-categorisation of Nutritional Borderline Substance (NBS) products – development and maintenance process
The NHS Business Services Authority (NHSBSA) has worked closely with the Department of Health and Social Care (DHSC) to improve the categorisation of NBS products. It is part of a system-wide move towards interoperability.
The work has been…
July 2023 Reimbursement Price Changes
The Department of Health and Social Care has confirmed that the following products in Part VIIIA of the Drug Tariff have had their reimbursement prices redetermined for July 2023 to reflect an increase in their NHS list price…
Medicines Data and the dm+d
Suppliers of medicinal products and medical devices have a vital role to play in maintaining the dictionary of medicines and devices (dm+d). The dm+d is the recognised NHS standard (SCC10052) for identifying and communicating medicinal product and…